UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long-Established Target Mitochondrial Pyruvate Carrier

Linyu Ran1,2, Miao Chen3, Jihui Ye1,2

  • 1Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai, 200120, China.

Insights

UK5099, an inhibitor of mitochondrial pyruvate carrier (MPC), potently inhibits the NLRP3 inflammasome, independent of MPC. This discovery offers new therapeutic avenues for NLRP3-driven diseases and impacts immunometabolism research.

Area of Science:

  • Immunology
  • Molecular Biology
  • Drug Discovery

Background:

  • The NLRP3 inflammasome is a key target for treating inflammatory diseases.
  • UK5099, an established mitochondrial pyruvate carrier (MPC) inhibitor, has shown anti-inflammatory effects independent of MPC.
  • The precise mechanisms of UK5099's anti-inflammatory action were previously unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying UK5099's anti-inflammatory effects.
  • To determine if UK5099 targets the NLRP3 inflammasome.
  • To explore the therapeutic potential of UK5099 in NLRP3-mediated inflammatory conditions.

Main Methods:

  • Assessed UK5099's effect on NLRP3 inflammasome activation in mouse and human macrophages.
  • Utilized macrophages lacking MPC expression to confirm MPC-independent activity.
  • Investigated the interaction between mitochondria and NLRP3 upon UK5099 treatment.
  • Evaluated the in vivo efficacy of UK5099 in an endotoxemia mouse model.
  • Performed structure-activity relationship studies on UK5099.

Main Results:

  • UK5099 demonstrated potent and selective inhibition of NLRP3 inflammasome activation, without affecting NLRC4 or AIM2.
  • The inhibitory effect of UK5099 on NLRP3 was confirmed to be independent of MPC expression.
  • UK5099 was found to disrupt the interaction between mitochondria and NLRP3, preventing inflammasome assembly.
  • A single dose of UK5099 significantly reduced IL-1β production in vivo.
  • Structural analysis indicated that the inhibitory activity of UK5099 is not dependent on its activated double bond.

Conclusions:

  • UK5099 is a novel and potent inhibitor of the NLRP3 inflammasome, acting via disruption of mitochondria-NLRP3 interaction.
  • This finding identifies UK5099 as a potential therapeutic agent for NLRP3-driven inflammatory diseases.
  • The MPC-independent NLRP3 inhibitory activity of UK5099 necessitates re-evaluation of its use in immunometabolism studies.

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Protein Transport into the Inner Mitochondrial Membrane01:34

Protein Transport into the Inner Mitochondrial Membrane

Nuclear encoded mitochondrial precursors are imported to the inner membrane in a multistep process involving two separate translocons, TIM22 and TIM23. TIM23 is a cation-selective pore that remains closed by the N terminal segment of the protein. Negative charges on the TIM23 act as a receptor for the incoming precursor, pulling the positively charged matrix-targeting sequence for peptide insertion and translocation.
Transport of mitochondrial precursors across the TIM23 channel is driven by...
3.7K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
2.6K
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
158.8K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.5K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.3K